|
|
Post by boytroy88 on Aug 7, 2024 7:02:26 GMT -5
|
|
|
|
Post by porkini on Aug 7, 2024 7:10:47 GMT -5
Pierced or clip-on?   |
|
|
|
Post by sportsrancho on Aug 7, 2024 7:14:29 GMT -5
“We achieved our ninth consecutive quarter of revenue growth and are approaching an annual revenue run rate of over $275 million based on the first half of 2024,” said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. “We are excited about our future as we move our orphan lung programs into Phase 1 and Phase 3 studies and look forward to the additional Afrezza data read-outs later this year. We believe our diversification strategy of allocating capital towards our pipeline, in-line growth and debt reduction sets us up to deliver sustainable short and long-term value for our shareholders.”
|
|
|
|
Post by boytroy88 on Aug 7, 2024 7:21:49 GMT -5
Pierced or clip-on? Lol... Sorry, wrote it on my mobile and just got up. 😁 |
|
|
|
Post by prcgorman2 on Aug 8, 2024 15:55:20 GMT -5
|
|
